financetom
Business
financetom
/
Business
/
Why Gillette Parent Procter & Gamble Shares Are Tumbling Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Gillette Parent Procter & Gamble Shares Are Tumbling Today
Jul 30, 2024 6:22 AM

Procter & Gamble Co ( PG ) shares are trading lower after the company reported fourth-quarter FY24 sales of $20.53 billion (flat Y/Y), missing the analyst consensus estimate of $20.74 billion.

Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, increased 2%. A one percent increase in all-in volume and one percent increase due to higher pricing were offset by two percentage points of unfavorable foreign exchange impacts.

Sales in the Beauty segment fell 1%, the Grooming segment remained flat, and Health Care increased 3%.

Adjusted EPS of $1.40 beat the analyst consensus of $1.37.

Gross profit increased 2% Y/Y to $10.18 billion. The reported gross margin increased by 120 basis points to 49.6%.

Operating margin contracted 140 basis points to 18.9%, while operating income for the quarter fell 7% to $3.88 billion.

P&G held $9.48 billion in cash and equivalents as of June-end. Operating cash flow for the quarter was $5.75 billion.

The company returned over $14 billion of value to shareholders in FY24 via $9.3 billion in dividend payments and $5 billion of share repurchases.

“The team met or exceeded our going-in plans for organic sales growth, core EPS growth, cash generation and cash returned to shareowners in a challenging economic and geopolitical environment,” said Board Chairman, President, and CEO Jon Moeller.

Outlook: P&G sees FY25 all-in sales growth of 2% – 4% and organic sales growth of 3% – 5%. This outlook equates to FY25 revenue of $85.72 billion – $87.40 billion versus an estimate of $86.856 billion. 

P&G expects its fiscal 2025 core net earnings per share growth of 5% – 7% versus fiscal 2024 core EPS of $6.59. This outlook equates to FY25 adjusted EPS of $6.91 – $7.05 versus an estimate of $6.97.

P&G said it expects adjusted free cash flow productivity of 90% and expects to pay around $10 billion in dividends and to repurchase $6 to $7 billion of common shares in fiscal 2025.

Price Action: PG shares are trading lower by 5.40% at $160.75 in premarket on the last check Tuesday.

Image from Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LightPath Technologies Files $200 Million Mixed Shelf
LightPath Technologies Files $200 Million Mixed Shelf
Nov 24, 2025
04:46 AM EST, 11/24/2025 (MT Newswires) -- LightPath Technologies ( LPTH ) filed late Friday a Form S-3 with the US Securities and Exchange Commission for the potential offering of up to $200 million worth of class A common shares, warrants and units. Net proceeds will be used for general corporate purposes, the company said. ...
Market Chatter: Warner Bros.' CNN Removes Stories From Apple News Amid Deal Dispute
Market Chatter: Warner Bros.' CNN Removes Stories From Apple News Amid Deal Dispute
Nov 24, 2025
04:56 AM EST, 11/24/2025 (MT Newswires) -- Warner Bros. Discovery's ( WBD ) CNN removed its content from Apple's ( AAPL ) news app over the weekend, Semafor reported Monday, citing unnamed sources. The companies are negotiating a possible new deal that would restore CNN's stories to Apple News, the report said. Warner Bros. and Apple ( AAPL ) didn't...
Merck Urges Shareholders to Reject Deep-Discount Mini-Tender Offer
Merck Urges Shareholders to Reject Deep-Discount Mini-Tender Offer
Nov 24, 2025
04:35 AM EST, 11/24/2025 (MT Newswires) -- Merck ( MRK ) said late Friday that shareholders should not participate in the unsolicited mini-tender offer launched by Tutanota at $65 per share, which is well below recent market prices. The company said Tutanota plans to buy up to 1 million of its shares, at a price more than 31% below last...
Clarivate Rolls Out Monitoring Tool to Streamline Intellectual Property, R&D Collaborative Patent Reviews
Clarivate Rolls Out Monitoring Tool to Streamline Intellectual Property, R&D Collaborative Patent Reviews
Nov 24, 2025
04:45 AM EST, 11/24/2025 (MT Newswires) -- Clarivate ( CLVT ) said Monday it launched a monitoring tool to streamline intellectual property and research and development collaborative patent reviews. The Derwent patent monitor provides artificial intelligence-powered evaluation of potential threats helping to accelerate first-pass reviews to surface the most critical risks for stakeholders, the company said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved